AP Insights, News, Videos, and More

The proportion of opioid overdose deaths involving the medication buprenorphine did not increase in the months after prescribing flexibilities were enacted as a result of the COVID-19 pandemic, according to new research from NIDA and the CDC.

Findings from researchers at Yale and several international universities indicate potential overlaps between different disorders that are influenced by the same genes and their variants.

SAMHSA has announced Notices of Funding Opportunities for 5 grant programs focused on substance use disorder treatment and prevention. The grants total about $73.4 million.

Pharmacists can safely and effectively start patients with opioid use disorder (OUD) on buprenorphine, according to a new pilot study from researchers at Brown University, Rhode Island Hospital, and the University of Rhode Island.

Exposure to benzodiazepines in utero is not associated with increased risks of autism spectrum disorder (ASD) or ADHD, study finds.

A 3-day limit on opioid prescriptions to treat surgical pain reduced the number of patients who became chronic opioid users without compromising pain relief or recovery, according to a recent study at Roswell Park Comprehensive Cancer Center.

In 2021, 46.3 million people aged 12 or older in the US—about 16.5% of the nation’s population—met the applicable DSM-5 criteria for having a substance use disorder, according to the latest National Survey on Drug Use and Health.

President Joe Biden signed the $1.7 trillion fiscal year 2023 omnibus appropriations bill into law, and it will impact behavioral healthcare and addiction treatment in multiple ways.

Chronic exposure to THC, the main psychoactive component in cannabis, may induce long-lasting memory impairments and increased anxiety, according to a study from the University of Western Ontario.